Director Dealing

Summary by AI BETAClose X

4basebio PLC announced that its Chief Executive Officer, Dr. Amy Walker, acquired 2,650 ordinary shares on February 13, 2026, for an aggregated purchase price of 586.08 pence per share. This transaction increases her total shareholding to 46,666 ordinary shares, representing 0.30% of the company's issued share capital, which comprises 15,538,518 ordinary shares. The purchase of these shares, which constitute approximately 0.02% of the company's issued share capital, is considered inside information.

Disclaimer*

Companies

4basebio (4BB)
UK 100

Latest directors dealings